Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Recent histone deacetylase inhibitors in cancer therapy
Roza Parveen, Divya Harihar, Biswa Prasun Chatterji
Cancer (2023) Vol. 129, Iss. 21, pp. 3372-3380
Closed Access | Times Cited: 43
Vorinostat (SAHA) and Breast Cancer: An Overview
Anna Wawruszak, Lidia Borkiewicz, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4700-4700
Open Access | Times Cited: 66
Silicon switch: Carbon–silicon Bioisosteric replacement as a strategy to modulate the selectivity, physicochemical, and drug‐like properties in anticancer pharmacophores
Jean Fotie, Caitlyn M. Matherne, Jordan E. Wroblewski
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 235-254
Closed Access | Times Cited: 29
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Márcia S. Pereira, Maria Teresa Cruz, Ana Fortuna, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104052-104052
Open Access | Times Cited: 7
SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages
Fan Yang, Zijie Gao, Jianye Xu, et al.
Theranostics (2023) Vol. 13, Iss. 10, pp. 3310-3329
Open Access | Times Cited: 20
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 17
Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer
Khaled Elsayad, Ghada F. Elmasry, Sally Tarek Mahmoud, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107409-107409
Closed Access | Times Cited: 5
HDAC10 and its implications in Sézary syndrome pathogenesis
Monika Pieniawska, Karolina Rassek, Bogumiła Skwara, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access
Epigenetic activation of PTEN by valproic acid inhibits PI3K/AKT signaling and Burkitt lymphoma cell growth
Chuntuan Li, Shengquan Liu, Jingjing Gao, et al.
Gene (2025) Vol. 950, pp. 149369-149369
Open Access
Mechanism of assembly, activation and lysine selection by the SIN3B histone deacetylase complex
Mandy S. M. Wan, Reyhan Muhammad, Marios G. Koliopoulos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Rui Han, Changquan Ling, Yuqian Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
Fares Saeed H. Al-Mansour, Abdullah Alraddadi, Buwei He, et al.
Aging (2023) Vol. 15, Iss. 7, pp. 2373-2394
Open Access | Times Cited: 10
Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer
Qinjin Dai, Ying Ye
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 17
Identification of proteomic landscape of drug-binding proteins in live cells by proximity-dependent target ID
Chulhwan Kwak, Cheolhun Park, Minjeong Ko, et al.
Cell chemical biology (2022) Vol. 29, Iss. 12, pp. 1739-1753.e6
Open Access | Times Cited: 16
Histone acetyltransferases and histone deacetyl transferases play crucial role during oogenesis and early embryo development
Nazlıcan Bozdemir, Fatma Uysal
genesis (2023) Vol. 61, Iss. 5
Closed Access | Times Cited: 9
Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis.
Niveditha Nerlakanti, Jeremy McGuire, Ryan T. Bishop, et al.
Cancer Letters (2024), pp. 217302-217302
Open Access | Times Cited: 2
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
Matthew J. Kling, Varun Kesherwani, Nitish K. Mishra, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 10
The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
Long Xu, Xiaoyu Yan, Jian Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15066-15066
Open Access | Times Cited: 5
Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer
Carter A. Wright, Emily R. Gordon, Sara J. Cooper
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Fisetin reduces the resistance of MOLT-4 and K562 cells to TRAIL-induced apoptosis through upregulation of TRAIL receptors
Lei Liu, Shaik Althaf Hussain, Xiaoyan Hu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9689-9700
Closed Access | Times Cited: 1
m6A-YTHDF1 Mediated Regulation of GRIN2D in Bladder Cancer Progression and Aerobic Glycolysis
Meixian Le, Meiying Qing, Xiangju Zeng, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs
Kinga Vojnits, Zhuohang Feng, Paige Johnson, et al.
Cancer Letters (2024) Vol. 599, pp. 217108-217108
Open Access | Times Cited: 1
Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma
Xuan Wang, Xiaoning Li, Wei Li, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
BET inhibitor JQ1 induces apoptosis of ovarian and endometrial endometrioid carcinoma cells by downregulating c‑Myc
Saki Tanimoto, Kenbun Sone, Yuri Jonouchi, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top